Cargando…

Hepatitis B-related hepatocellular carcinoma: surveillance strategy directed by immune-epidemiology

Hepatitis B infection (HBV) is one of the most common causes of hepatocellular carcinoma (HCC) worldwide. The age of occurrence, prognosis and incidence vary dramatically depending on the region of the world. This geographic variation is largely dependent on the contrasting incidence of HBV, age of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anugwom, Chimaobi M., Allaire, Manon, Akbar, Sheikh Mohammad Fazle, Sultan, Amir, Bollipo, Steven, Mattos, Angelo Z., Debes, Jose D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057710/ https://www.ncbi.nlm.nih.gov/pubmed/33884303 http://dx.doi.org/10.20517/2394-5079.2021.06

Ejemplares similares

Hepatocellular carcinoma in Hepatitis B and Human Immunodeficiency Virus coinfection in Africa: a focus on surveillance
por: Wan, Qian, et al.
Publicado: (2022)

A Case of Infiltrative Hepatocellular Carcinoma With Vascular Invasion Into the Heart
por: Anugwom, Chimaobi M, et al.
Publicado: (2021)

Inverse Association Between Chronic Hepatitis B Infection and Coronavirus Disease 2019 (COVID-19): Immune Exhaustion or Coincidence?
por: Anugwom, Chimaobi M, et al.
Publicado: (2020)

The Role of Cytokines in the Different Stages of Hepatocellular Carcinoma
por: Rico Montanari, Noe, et al.
Publicado: (2021)

Hepatitis E virus infection in the United States: Seroprevalence, risk factors and the influence of immunological assays
por: Pisano, María Belén, et al.
Publicado: (2022)

Systematic analysis of acute liver injury during SARS-CoV-2 infection
por: Debes, Jose D., et al.
Publicado: (2020)

Assessment of STAT4 Variants and Risk of Hepatocellular Carcinoma in Latin Americans and Europeans
por: Ayoub, Alan, et al.
Publicado: (2023)

Understanding immune perspectives and options for the use of checkpoint immunotherapy in HCC post liver transplant
por: Anugwom, Chimaobi M., et al.
Publicado: (2022)

Nivolumab-Induced Autoimmune-Like Cholestatic Hepatitis in a Liver Transplant Recipient
por: Anugwom, Chimaobi, et al.
Publicado: (2020)

Thyroid Disease–Induced Hepatic Dysfunction: A Clinical Puzzle
por: Anugwom, Chimaobi M., et al.
Publicado: (2021)

Immune aspects of hepatocellular carcinoma: From immune markers for early detection to immunotherapy
por: Mattos, Ângelo Z, et al.
Publicado: (2021)

Epidemiology of Hepatitis E Virus in an Urban Community in Dhaka City
por: Rahman, Salimur, et al.
Publicado: (2014)

Case of Primary Hepatic Angiosarcoma Presenting With Jaundice and Infiltrative Liver Masses
por: Shaaban, Adnan, et al.
Publicado: (2022)

Vanishing Bile Duct Syndrome Preceding the Diagnosis of Hodgkin Lymphoma
por: Anugwom, Chimaobi, et al.
Publicado: (2020)

Lower survival and higher rates of cirrhosis in patients with ROUX-EN-Y gastric bypass hospitalised with alcohol-associated hepatitis
por: Anugwom, Chimaobi, et al.
Publicado: (2023)

Serum Biomarkers for the Prediction of Hepatocellular Carcinoma
por: Debes, José D., et al.
Publicado: (2021)

Non-alcoholic fatty liver disease-related hepatocellular carcinoma: Is there a role for immunotherapy?
por: Mattos, Ângelo Z, et al.
Publicado: (2022)

Immune therapies against chronic hepatitis B
por: Akbar, Sheikh Mohammad Fazle, et al.
Publicado: (2022)

Hepatocellular carcinoma in nonalcoholic fatty liver disease: A growing challenge
por: Mattos, Ângelo Z, et al.
Publicado: (2021)

L-Asparaginase-Induced Hepatotoxicity Treated Successfully With L-Carnitine and Vitamin B Infusion
por: Lee, Christina, et al.
Publicado: (2021)

Protein-losing Enteropathy Due to Inferior Vena Cava Stenosis in a Liver Transplant Recipient
por: Anugwom, Chimaobi M., et al.
Publicado: (2021)

Hepatocellular Carcinoma Occurrence and Recurrence in Hepatitis C-infected Patients Treated with Direct-acting Antivirals
por: Syed, Taseen, et al.
Publicado: (2018)

Aceruloplasminemia: A Case Report and Review of a Rare and Misunderstood Disorder of Iron Accumulation
por: Anugwom, Chimaobi M, et al.
Publicado: (2020)

Action Mechanisms and Scientific Rationale of Using Nasal Vaccine (HeberNasvac) for the Treatment of Chronic Hepatitis B
por: Aguilar, Julio Cesar, et al.
Publicado: (2022)

Clinical and epidemiological aspects of hepatocellular carcinoma in Brazil
por: Carrilho, Flair Jose, et al.
Publicado: (2010)

Current impact of viral hepatitis on liver cancer development: The challenge remains
por: de Mattos, Ângelo Zambam, et al.
Publicado: (2021)

EDITORIAL
por: Akbar, Sheikh Mohammad Fazle
Publicado: (2019)

Co-existence of a pandemic (SARS-CoV-2) and an epidemic (Dengue virus) at some focal points in Southeast Asia: Pathogenic importance, preparedness, and strategy of tackling
por: Khan, Sakirul, et al.
Publicado: (2022)

Development of Therapeutic Vaccine for Chronic Hepatitis B: Concept, Cellular and Molecular Events, Design, Limitation, and Future Projection
por: Akbar, Sheikh Mohammad Fazle, et al.
Publicado: (2022)

Prevalence and risk of hepatitis E virus infection in the HIV population of Nepal
por: Shrestha, Ananta, et al.
Publicado: (2017)

The Role of Hepatocellular Carcinoma Surveillance in Autoimmune Hepatitis
por: Manivannan, Ahila, et al.
Publicado: (2020)

Development of Therapy Based on the Exploration of Biological Events Underlying the Pathogenetic Mechanisms of Chronic Hepatitis B Infection
por: Akbar, Sheikh Mohammad Fazle, et al.
Publicado: (2023)

EDITORIAL
por: Akbar, Sheikh Mohammad Fazle, et al.
Publicado: (2019)

Hepatocellular carcinoma with portal invasion, still a place for liver surgery in the era of immunotherapy?
por: Giudicelli, Héloïse, et al.
Publicado: (2022)

Hepatocellular carcinoma surveillance: current practice and future directions
por: Ahn, Joseph C., et al.
Publicado: (2022)

Antiviral Response across Genotypes after Treatment of Chronic Hepatitis B Patients with the Therapeutic Vaccine NASVAC or Pegylated Interferon
por: Al-Mahtab, Mamun, et al.
Publicado: (2023)

Characterizing the mechanism behind the progression of NAFLD to hepatocellular carcinoma
por: Nahon, Pierre, et al.
Publicado: (2020)

Evaluation of Rapid Diagnostic Tests for Assessment of Hepatitis B in Resource-Limited Settings
por: Leathers, James S., et al.
Publicado: (2019)

Surveillance for hepatocellular carcinoma in chronic viral hepatitis: Is it time to personalize it?
por: Demirtas, Coskun Ozer, et al.
Publicado: (2021)

MBOAT7 rs641738 Variant Is Not Associated with an Increased Risk of Hepatocellular Carcinoma in a Latin American Cohort
por: Goble, Spencer, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p06mustfdqcq3s1kivj77kr3g3